Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Nucleic Acids Research
|
November 16, 2020
CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
Augustin Luna, Fathi Elloumi, Sudhir Varma, et al.
Iscience
|
June 13, 2024
Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines
Camille Tlemsani, Christine M Heske, Fathi Elloumi, et al.
Cancer Research
|
May 23, 2019
RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB
William C Reinhold, Sudhir Varma, Margot Sunshine, et al.
STAR Protocols
|
September 26, 2025
Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line data
Fathi Elloumi, Camille Tlemsani, Christine M Heske, et al.
Cancer Research
|
October 28, 2017
NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH<sup>+</sup> Cancer Stem-like Cells
Carrie D House, Elizabeth Jordan, Lidia Hernandez, et al.
Molecular Cancer Therapeutics
|
June 4, 2025
Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA Alkylating Agents in Glioma
Nicole J Briceno, Jinkyu Jung, Aiguo Li, et al.
Plos One
|
January 29, 2021
Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development
Fumiya Moribe, Momoko Nishikori, Tsuyoshi Takashima, et al.
Biorxiv : the Preprint Server for Biology
|
April 28, 2025
Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinoma
Anjali Dhall, Daiki Taniyama, Fathi Elloumi, et al.
Cancers
|
July 12, 2025
Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical Carcinoma
Anjali Dhall, Daiki Taniyama, Fathi Elloumi, et al.
Molecular Cancer Therapeutics
|
May 28, 2021
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents
Ukhyun Jo, Ilya S Senatorov, Astrid Zimmermann, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Nucleic Acids Research
|
November 16, 2020
CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
Augustin Luna, Fathi Elloumi, Sudhir Varma, et al.
Iscience
|
June 13, 2024
Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines
Camille Tlemsani, Christine M Heske, Fathi Elloumi, et al.
Cancer Research
|
May 23, 2019
RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB
William C Reinhold, Sudhir Varma, Margot Sunshine, et al.
STAR Protocols
|
September 26, 2025
Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line data
Fathi Elloumi, Camille Tlemsani, Christine M Heske, et al.
Cancer Research
|
October 28, 2017
NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH<sup>+</sup> Cancer Stem-like Cells
Carrie D House, Elizabeth Jordan, Lidia Hernandez, et al.
Molecular Cancer Therapeutics
|
June 4, 2025
Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA Alkylating Agents in Glioma
Nicole J Briceno, Jinkyu Jung, Aiguo Li, et al.
Plos One
|
January 29, 2021
Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development
Fumiya Moribe, Momoko Nishikori, Tsuyoshi Takashima, et al.
Biorxiv : the Preprint Server for Biology
|
April 28, 2025
Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinoma
Anjali Dhall, Daiki Taniyama, Fathi Elloumi, et al.
Cancers
|
July 12, 2025
Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical Carcinoma
Anjali Dhall, Daiki Taniyama, Fathi Elloumi, et al.
Molecular Cancer Therapeutics
|
May 28, 2021
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents
Ukhyun Jo, Ilya S Senatorov, Astrid Zimmermann, et al.
Page
of 4